Preliminary PET imaging of [ 11 C]evobrutinib in mouse models of colorectal cancer, SARS‐CoV‐2, and lung damage: Radiosynthesis via base‐aided palladium‐NiXantphos‐mediated 11 C‐carbonylation
Journal of Labelled Compounds and Radiopharmaceuticals · 2024
DOI: 10.1002/jlcr.4062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Amanda J Boyle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Centre for Neuro-Radiochemistry, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Carbon Radioisotopes, Colorectal Neoplasms, Palladium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Azrieli Foundation, Canada Research Chairs Program, Canada Foundation for Innovation.
Abstract (Originalsprache)
Evobrutinib is a second‐generation, highly selective, irreversible Bruton's tyrosine kinase (BTK) inhibitor that has shown efficacy in the autoimmune diseases arthritis and multiple sclerosis. Its development as a positron emission tomography (PET) radiotracer has potential for in vivo imaging of BTK in various disease models including several cancers, severe acute respiratory syndrome‐coronavirus‐2 (SARS‐CoV‐2), and lipopolysaccharide (LPS)‐induced lung damage. Herein, we report the automated radiosynthesis of [ 11 C]evobrutinib using a base‐aided palladium‐NiXantphos‐mediated 11 C‐carbonylation reaction. [ 11 C]Evobrutinib was reliably formulated in radiochemical yields of 5.5 ± 1.5% and a molar activity of 34.5 ± 17.3 GBq/μmol ( n = 12) with 99% radiochemical purity. Ex vivo autoradiography studies showed high specific binding of [ 11 C]evobrutinib in HT‐29 colorectal cancer mouse xenograft tissues (51.1 ± 7.1%). However, in vivo PET/computed tomography (CT) imaging with [ 11 C]evobrutinib showed minimal visualization of HT‐29 colorectal cancer xenografts and only a slight increase in radioactivity accumulation in the associated time‐activity curves. In preliminary PET/CT studies, [ 11 C]evobrutinib failed to visualize either SARS‐CoV‐2 pseudovirus infection or LPS‐induced injury in mouse models. In conclusion, [ 11 C]evobrutinib was successfully synthesized by 11 C‐carbonylation and based on our preliminary studies does not appear to be a promising BTK‐targeted PET radiotracer in the rodent disease models studied herein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Azrieli Centre for Neuro-Radiochemistry, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Brain Health Imaging Centre, Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, Ontario, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Amanda J Boyle, Neil Vasdev
Förderung
- Azrieli Foundation
- Canada Research Chairs Program
- Canada Foundation for Innovation
- Ontario Research Fund
- Canada Excellence Research Chairs, Government of Canada
Zitieren
APA
Boyle, A. J., Lindberg, A., Tong, J., Zhai, D., Liu, F., & Vasdev, N. (2024). Preliminary PET imaging of [ 11 C]evobrutinib in mouse models of colorectal cancer, SARS‐CoV‐2, and lung damage: Radiosynthesis via base‐aided palladium‐NiXantphos‐mediated 11 C‐carbonylation. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4062
Vancouver
Boyle AJ, Lindberg A, Tong J, Zhai D, Liu F, Vasdev N. Preliminary PET imaging of [ 11 C]evobrutinib in mouse models of colorectal cancer, SARS‐CoV‐2, and lung damage: Radiosynthesis via base‐aided palladium‐NiXantphos‐mediated 11 C‐carbonylation. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4062
BibTeX
@article{Boyle2024,
author = {Boyle, Amanda J and Lindberg, Anton and Tong, Junchao and Zhai, Dongxu and Liu, Fang and Vasdev, Neil},
title = {Preliminary PET imaging of [ 11 C]evobrutinib in mouse models of colorectal cancer, SARS‐CoV‐2, and lung damage: Radiosynthesis via base‐aided palladium‐NiXantphos‐mediated 11 C‐carbonylation},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2024},
doi = {10.1002/jlcr.4062}
}
EUVIMED